JPM Thematics - Genetic Therapies C (dist) - USD/  LU2309826514  /

Fonds
NAV30/05/2024 Var.+0.3500 Type of yield Focus sugli investimenti Società d'investimento
56.5400USD +0.62% paying dividend Equity Worldwide JPMorgan AM (EU) 

Investment strategy

To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally. Will invest in equities of companies that have been identified by the Investment Manager as being involved in research, development, production or marketing of genetic therapies and their associated businesses anywhere in the world, including emerging markets. The Investment Manager supervises and monitors the theme identification and portfolio construction process and actively selects securities for the Sub-Fund"s portfolio. At least 90% of companies purchased will be analysed against the theme.
 

Investment goal

To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
 

Dati master

Type of yield: paying dividend
Fondi Categoria: Equity
Region: Worldwide
Settore: Sector Health / Pharma
Benchmark: MSCI All Country World Index (Total Return Net)
Business year start: 01/07
Ultima distribuzione: 13/09/2023
Banca depositaria: J.P. Morgan SE - Zweigniederlassung Luxemburg
Domicilio del fondo: Luxembourg
Permesso di distribuzione: Austria, Germany, Switzerland, Luxembourg
Gestore del fondo: Yazann Romahi, Aijaz Hussain
Volume del fondo: 588.01 mill.  USD
Data di lancio: 10/03/2021
Investment focus: -

Condizioni

Sovrapprezzo emissione: 0.00%
Tassa amministrativa massima: 0.36%
Investimento minimo: 10,000,000.00 USD
Deposit fees: -
Redemption charge: 0.00%
Prospetto semplificato: Download (Print version)
 

Società d'investimento

Funds company: JPMorgan AM (EU)
Indirizzo: PO Box 275, 2012, Luxembourg
Paese: Luxembourg
Internet: www.jpmorganassetmanagement.de
 

Attività

Stocks
 
99.37%
Mutual Funds
 
0.63%

Paesi

United States of America
 
76.62%
Switzerland
 
8.07%
Japan
 
5.63%
Germany
 
2.30%
Australia
 
1.91%
France
 
1.31%
China
 
1.00%
Taiwan, Province Of China
 
0.72%
Netherlands
 
0.66%
Korea, Republic Of
 
0.62%
Singapore
 
0.32%
United Kingdom
 
0.24%
Altri
 
0.60%

Filiali

Pharma/Biotechnology
 
87.07%
Healthcare services
 
11.49%
Healthcare appliances
 
0.78%
Altri
 
0.66%